Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 38

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications

Sutherland, Jeffrey J., Morrison, Ryan D., McNaughton, Candace D., Daly, Thomas M., Milne, Stephen B., Daniels, J. Scott, Ryan, Timothy P. · 2018 · JAMA Network Open

Abstract

Importance: Inaccurate medication records and poor medication adherence result in incomplete knowledge of therapy for patients. Objective: To study accuracy of medical records and patient adherence by measuring blood concentrations of medications. Design, Setting, and Participants: This cross-sectional study validated a serum-based liquid chromatography-tandem mass spectrometry assay to simultaneously quantify 263 medications used for acute and chronic conditions. The assay panel was applied to 3 clinical patient cohorts: residual serum from 1000 randomly selected samples sent for routine clinical chemistry testing between April 8 and October 6, 2015 (residuals cohort), 50 prospectively enrolled patients in a gastroenterology clinic between March 1 and March 15, 2016, who were prescribed more than 5 medications (gastroenterology care cohort), and a convenience cohort of 296 patients with hypertension who sought care in an emergency department (ED care cohort) between July 1, 2012, and April 25, 2013. Integrated data analysis of the cohorts was performed from August 22 to November 29, 2017. Main Outcomes and Measures: Medication serum concentrations, electronic health record medication lists, and predicted drug interactions. Results: Of the 1346 total samples, 1000 came from the residuals cohort (640 women and 360 men; median age, 60 years [interquartile range (IQR), 44-71 years]), 50 from the gastroenterology care cohort (30 women and 20 men; median age, 66 years [IQR, 62-70 years]), and 296 from the ED care cohort (160 women and 136 men; median age, 59 years [IQR, 52-66 years]). Median medication adherence, defined as the subset of detected medications from the prescription record, was 83% (IQR, 50%-100%) in the residuals cohort, 100% (IQR, 84%-100%) in the gastroenterology care cohort, and 78% (IQR, 57%-100%) in the ED care cohort. Patients adherent to 1 medication were more often adherent to other medications. Among patients prescribed 3 medications or more, there were no significant associations between medication adherence and sex or number of prescribed medications, and there was a modest association between adherence and age. By comparing detected vs prescribed medications, we detected a median of 0 (IQR, 0-2) medications per patient that were not listed in the electronic health record in the residuals cohort, 1 (IQR, 0-2) medication per patient that was not listed in the electronic health record in the gastroenterology care cohort, and 1 (IQR, 0-2) medication per patient that was not listed in the electronic health record in the ED care cohort. A total of 435 patients (43.5%) in the residuals cohort had no discrepancy between the electronic health record and detected medication lists, 22 patients (44.0%) in the gastroenterology care cohort had no discrepancy between the electronic health record and detected medication lists, and 41 patients (13.9%) in the ED care cohort had no discrepancy between the electronic health record and detected medication lists. Half of adverse drug reaction alerts occurred among medications detected without prescription. Conclusions and Relevance: Comprehensive medication monitoring offers promise to improve adherence, the accuracy of medical records, and the safety for patients with polypharmacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2018.4196

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 12

  1. Hiemke, 2011, AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011., Pharmacopsychiatry, 44, 195, 10.1055/s-0031-1286287 · DOI · Paper page
  2. Gudin, 2013, Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use., Postgrad Med, 125, 115, 10.3810/pgm.2013.07.2684 · DOI · Paper page
  3. Gervasini, 2010, Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy., Eur J Clin Pharmacol, 66, 755, 10.1007/s00228-010-0857-7 · DOI
  4. Kootstra-Ros, 2006, Therapeutic drug monitoring of antidepressants and cytochrome p450 genotyping in general practice., J Clin Pharmacol, 46, 1320, 10.1177/0091270006293754 · doi:10.1177/0091270006293754
  5. Ryan, 2017, Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring., PLoS One, 12, e0185471, 10.1371/journal.pone.0185471 · DOI
  6. Sutherland, 2017, Managing psychotropic medications in complex, real-world patients using comprehensive therapeutic drug monitoring., ACS Chem Neurosci, 8, 1641, 10.1021/acschemneuro.7b00209 · doi:10.1021/acschemneuro.7b00209
  7. Sutherland, 2015, Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactions., PLoS One, 10, e0118991, 10.1371/journal.pone.0118991 · DOI
  8. Sutherland, 2018, Medication exposure in highly adherent psychiatry patients., ACS Chem Neurosci, 9, 555, 10.1021/acschemneuro.7b00375 · DOI
  9. McNaughton, 2017, Systolic blood pressure and biochemical assessment of adherence: a cross-sectional analysis in the emergency department., Hypertension, 70, 307, 10.1161/HYPERTENSIONAHA.117.09659 · DOI
  10. Dasgupta, 2012, Therapeutic Drug Monitoring: Newer Drugs and Biomarkers, 10.1016/B978-0-12-385467-4.00001-4 · DOI
  11. Aitken, 2013, Avoidable Costs in US Healthcare: The $200 Billion Opportunity From Using Medicines More Responsibly
  12. Kleinrock, 2012, The Use of Medicines in the United States: Review of 2011

Cited by

Metadata

Authors
Sutherland, J. J., Morrison, R. D., McNaughton, C. D., Daly, T. M., Milne, S. B., Daniels, J. S., & Ryan, T. P.
Affiliations
  • Precera Bioscience, Franklin, Tennessee
  • Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
  • Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Venue
JAMA Network Open
Published
2018-11-02
Volume
1
Issue
7
Pages
e184196
ISSN
2574-3805
Cited by
38
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.